JP2017538779A5 - - Google Patents

Download PDF

Info

Publication number
JP2017538779A5
JP2017538779A5 JP2017538458A JP2017538458A JP2017538779A5 JP 2017538779 A5 JP2017538779 A5 JP 2017538779A5 JP 2017538458 A JP2017538458 A JP 2017538458A JP 2017538458 A JP2017538458 A JP 2017538458A JP 2017538779 A5 JP2017538779 A5 JP 2017538779A5
Authority
JP
Japan
Prior art keywords
nebulizer
seq
polypeptide
composition
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017538458A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017538779A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/073487 external-priority patent/WO2016055656A1/en
Publication of JP2017538779A publication Critical patent/JP2017538779A/ja
Publication of JP2017538779A5 publication Critical patent/JP2017538779A5/ja
Withdrawn legal-status Critical Current

Links

JP2017538458A 2014-10-10 2015-10-09 Rsv感染の治療方法 Withdrawn JP2017538779A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201462062469P 2014-10-10 2014-10-10
US62/062,469 2014-10-10
US201462067096P 2014-10-22 2014-10-22
US62/067,096 2014-10-22
US201462074842P 2014-11-04 2014-11-04
US62/074,842 2014-11-04
EP14193094 2014-11-13
EP14193094.1 2014-11-13
PCT/EP2015/073487 WO2016055656A1 (en) 2014-10-10 2015-10-09 Methods of treating rsv infections

Publications (2)

Publication Number Publication Date
JP2017538779A JP2017538779A (ja) 2017-12-28
JP2017538779A5 true JP2017538779A5 (https=) 2018-11-08

Family

ID=83280658

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017538458A Withdrawn JP2017538779A (ja) 2014-10-10 2015-10-09 Rsv感染の治療方法

Country Status (10)

Country Link
US (1) US10561805B2 (https=)
EP (1) EP3204041A1 (https=)
JP (1) JP2017538779A (https=)
KR (1) KR20170093120A (https=)
CN (1) CN107206069A (https=)
AU (1) AU2015329936A1 (https=)
CA (1) CA2963037A1 (https=)
RU (1) RU2017115670A (https=)
SG (1) SG11201702688UA (https=)
WO (1) WO2016055656A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204095B8 (en) * 2014-10-10 2019-07-10 Ablynx N.V. Inhalation device for use in aerosol therapy of respiratory diseases
US20170100304A1 (en) * 2015-10-13 2017-04-13 Hill-Rom Services Pte Limited Percussive chest therapy apparatus having a nebulizer interface
CN109311968A (zh) * 2016-05-02 2019-02-05 埃博灵克斯股份有限公司 治疗rsv感染
WO2017192774A1 (en) 2016-05-03 2017-11-09 Pneuma Respiratory, Inc. Methods for the systemic delivery of therapeutic agents to the pulmonary system using a droplet delivery device
EP3452150B1 (en) 2016-05-03 2024-01-17 Pneuma Respiratory, Inc. Droplet delivery device for delivery of fluids to the pulmonary system
WO2017192773A1 (en) 2016-05-03 2017-11-09 Pneuma Respiratory, Inc. Methods for treatment of pulmonary lung diseases with improved therapeutic efficacy and improved dose efficiency
WO2017192782A1 (en) 2016-05-03 2017-11-09 Pneuma Respiratory, Inc. Systems and methods comprising a droplet delivery device and a breathing assist device for therapeutic treatment
EP3452152B1 (en) 2016-05-03 2025-07-02 Pneuma Respiratory, Inc. A droplet delivery device for generating and delivering droplets to the pulmonary system
WO2018099968A1 (en) 2016-11-29 2018-06-07 Ablynx N.V. Treatment of infection by respiratory syncytial virus (rsv)
EP4223335A3 (en) 2017-05-19 2023-11-08 Pneuma Respiratory, Inc. Dry powder delivery device and methods of use
JP2020536614A (ja) 2017-10-04 2020-12-17 ニューマ・リスパイラトリー・インコーポレイテッド 呼吸により電気的に作動するインライン液滴送達装置および使用方法
CA3079189A1 (en) 2017-10-17 2019-04-25 Pneuma Respiratory, Inc. Nasal drug delivery apparatus and methods of use
JP2021502178A (ja) 2017-11-08 2021-01-28 ニューマ・リスパイラトリー・インコーポレイテッド 小容積アンプルを有して呼吸により電気的に作動するインライン液滴送達装置および使用方法
US11185252B2 (en) * 2018-10-18 2021-11-30 Koninklijke Philips N.V. Determining a risk level posed by an air pollutant
US20200360477A1 (en) 2019-05-16 2020-11-19 Aerovate Therapeutics, Inc. Inhalable formulations for kinase inhibition
WO2021230875A1 (en) * 2020-05-14 2021-11-18 Healthy Humming, LLC Therapeutic device for treatment of conditions relating to the sinuses, nasal cavities, ear, nose and throat
PL4359046T3 (pl) 2021-06-22 2025-10-13 Pneuma Respiratory, Inc. Urządzenie do podawania kropelkowego z wyrzutem wypychającym
US12161795B2 (en) 2022-07-18 2024-12-10 Pneuma Respiratory, Inc. Small step size and high resolution aerosol generation system and method
AR131494A1 (es) 2022-12-23 2025-03-26 Ablynx Nv Vehículos de conjugación a base de proteína
TW202543670A (zh) 2023-12-22 2025-11-16 比利時商艾伯霖克斯公司 用於核內投予之基於蛋白質的接合載劑
WO2025186422A1 (en) * 2024-03-07 2025-09-12 Csl Behring Ag Treatment and prevention of respiratory diseases
US20260007757A1 (en) 2024-06-18 2026-01-08 Ablynx Nv Antibody-recruiting molecules

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368684B2 (en) 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
DK1621554T4 (da) 1992-08-21 2012-12-17 Univ Bruxelles Immunoglobuliner blottet for lette kæder
KR20010034512A (ko) 1998-02-19 2001-04-25 베렌슨, 론 림프구 활성화 조절을 위한 조성물 및 그 방법
US20060073141A1 (en) 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
EP1578917A4 (en) * 2001-07-19 2008-01-23 Perlan Therapeutics Inc MULTIMEDIA PROTEINS AND METHODS FOR THE PRODUCTION AND USE THEREOF
US9320792B2 (en) 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
US7461263B2 (en) 2003-01-23 2008-12-02 Unspam, Llc. Method and apparatus for a non-revealing do-not-contact list system
EP1656128A4 (en) 2003-08-12 2007-02-28 William M Yarbrough SINGLE ACNE TREATMENT AND METHOD OF USE
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
CA2561845C (en) 2004-04-02 2014-03-25 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Aerosol delivery systems and methods
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0521621D0 (en) 2005-10-24 2005-11-30 Domantis Ltd Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases
MX2007006593A (es) 2004-12-02 2008-03-04 Domantis Ltd Anticuerpos de dominio simple anti-il 1r1 y sus usos terapeuticos.
EP2441838A3 (en) 2006-01-24 2013-07-10 Domantis Limited Fusion proteins that contain natural junctions
US8225785B2 (en) 2006-10-03 2012-07-24 Smiths Medical Asd, Inc. Vibratory PEP therapy system with medicated aerosol nebulizer
EP2121757A2 (en) 2007-02-21 2009-11-25 Ablynx N.V. Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
WO2008116165A2 (en) 2007-03-21 2008-09-25 Next Safety, Inc. Methods and systems of delivering medication via inhalation
CA2687903C (en) 2007-05-24 2016-09-13 Ablynx N.V. Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
PT2285439E (pt) 2008-04-04 2014-03-25 Nektar Therapeutics Dispositivo de aerossolização
LT2285408T (lt) * 2008-06-05 2019-01-25 Ablynx N.V. Aminorūgščių sekos, nukreiptos prieš viruso apvalkalo baltymus, ir tokias sekas turintys polipeptidai, skirti virusinių ligų gydymui
JP5713406B2 (ja) 2008-12-02 2015-05-07 クール セラピューティクス, インコーポレイテッド 微細氷粒子を有する呼吸ガスの送達のためのシステム
TWI541021B (zh) * 2009-03-05 2016-07-11 艾伯維有限公司 Il-17結合蛋白
PT2438087T (pt) * 2009-06-05 2017-08-04 Ablynx Nv Construções de nanobody trivalentes de vírus sincicial respiratório humano (hrsv) para a prevenção e/ou tratamento de infeções do trato respiratório
JP5762408B2 (ja) * 2009-08-13 2015-08-12 クルセル ホランド ベー ヴェー ヒト呼吸器合胞体ウイルス(rsv)に対する抗体および使用方法
US9352107B2 (en) 2010-01-07 2016-05-31 Koninklijke Philips N.V. Respiratory drug delivery apparatus including a feedback and compliance device
DK2533761T3 (da) * 2010-02-11 2019-06-24 Ablynx Nv Fremgangsmåder og sammensætninger til fremstilling af aerosoler
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
WO2012173992A1 (en) 2011-06-17 2012-12-20 Nostrum Technology Llc Mask for administration of inhaled medication
WO2013067164A1 (en) 2011-11-04 2013-05-10 Discovery Laboratories, Inc. Ventilation circuit adaptor and proximal aerosol delivery system
PT2797652T (pt) 2011-12-27 2019-02-19 Vectura Gmbh Dispositivo para inalação com sistema de feedback
EP2724741B1 (en) 2012-10-26 2017-06-14 Vectura GmbH Inhalation device for use in aerosol therapy
EP2846859B1 (en) 2012-03-09 2017-01-04 Vectura GmbH Mixing channel for an inhalation device and inhalation device
AU2013249280B2 (en) * 2012-04-17 2017-10-12 Gilead Sciences, Inc. Compounds and methods for antiviral treatment
TWI659968B (zh) 2013-03-14 2019-05-21 再生元醫藥公司 針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法

Similar Documents

Publication Publication Date Title
JP2017538779A5 (https=)
RU2017115670A (ru) Лечение инфекции рсв
EP3204095B1 (en) Inhalation device for use in aerosol therapy of respiratory diseases
AU2006235632B2 (en) Nitric oxide decontamination of the upper respiratory tract
JP2006513139A5 (https=)
MEP30108A (en) Formoterol superfine formulation
TW200618810A (en) Treatment of respiratory syncytial virus (RSV) infection
WO2008012531A3 (en) Delivery of gases to the nasal airway
WO2006059108A3 (en) ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES
US20150047635A1 (en) Duckbill valve and inhalation device including such a valve
JP2023517611A5 (https=)
JP2019513436A5 (https=)
Nitesh et al. What we learned in the past year in managing our COVID-19 patients in intensive care units?
WO2018099968A1 (en) Treatment of infection by respiratory syncytial virus (rsv)
AU2006225333A1 (en) Combination therapy of respiratory diseases using antibodies
WO2005110052A3 (en) The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
CN104436386B (zh) 辅助呼吸气雾气体的装置及调节呼吸气雾气体的方法
CN204233551U (zh) 辅助呼吸气雾气体的装置
HK1235327A1 (en) Inhalation device for use in aerosol therapy of respiratory diseases
HK1235327B (en) Inhalation device for use in aerosol therapy of respiratory diseases
NZ730120B2 (en) Inhalation device for use in aerosol therapy of respiratory diseases
Wongtrakool et al. A78 AIRWAY SMOOTH MUSCLE: WHAT'S UNDER THE HOOD?: Nicotine-Induced Airway Hyperresponsiveness May Be Due To Inappropriate Lynx1 Levels In Airway Smooth Muscle Cells
Oden et al. STOP-ROP Effective FiO2 Conversion Tables for Infants on Nasal Cannula
CN109833548A (zh) 肺部护理雾化器
AT501041B1 (de) Therapeutisches system zur transmukosolen applikation eines vasokonstriktors durch die nasenschleimhaut